Rhythm Biosciences LimitedASX: RHY

Board Renewal / Composition Update

· Issued by Rhythm Biosciences Limited

Filed with ASX · · 2 pages · English

Summary by 6ix AI

Rhythm Biosciences Limited has announced updates regarding its Board composition and renewal initiatives. Dr. David Atkins will join the Board as Managing Director immediately, while Dr. Trevor Lockett and Mr. Lou Panaccio will retire at the upcoming Annual General Meeting. Mr. Otto Buttula will also step down as Chair before the end of the calendar year, with ongoing discussions for new directors including a new Chair. The company acknowledges the contributions of retiring directors and expresses gratitude for their service since the company's inception.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Rhythm Biosciences Limited on 6ix

Earlier from Rhythm Biosciences

Later from Rhythm Biosciences

All Rhythm Biosciences news releases